New research highlighted by the European Medical Journal is drawing attention to TWIST1, a gene now linked with improved stability in atherosclerotic plaques.
Atherosclerosis is a condition where fatty deposits and other materials build up inside arteries, forming plaques. A major concern in this disease is plaque rupture, a sudden breakdown that can trigger serious cardiovascular events. The new data add a different angle to that long standing focus by indicating that TWIST1 driven plaques may be less likely to rupture and could instead show features associated with stability.
The report points to evidence suggesting that TWIST1 activity is connected with plaques that may hold together better, rather than becoming fragile. This is important because plaque behaviour, not just plaque size, is a key part of how doctors and researchers assess risk. When plaques remain stable, the immediate danger of rupture related complications is considered lower than in plaques that are vulnerable.
According to the update, the findings encourage a shift in how TWIST1 is viewed within atherosclerosis research. Instead of being treated only as a potential driver of harmful plaque changes, TWIST1 is now being discussed in relation to mechanisms that could support plaque stability.
The European Medical Journal notes that this reframes ongoing scientific questions in the field. Researchers studying artery disease often investigate why some plaques rupture while others remain intact over time. Data that connect TWIST1 with stability suggest that gene driven pathways may influence which direction a plaque takes.
The update also underscores that these insights may shape future research priorities around atherosclerosis, particularly around identifying biological signals linked to stable plaques. Understanding stability at the molecular level is one of the ways scientists aim to refine how cardiovascular risk is evaluated in the future.
The findings were published on March 3, 2026, as reported by the European Medical Journal.